Exploit: Ransomware
Lupin: Drugmaker
Risk to Small Business: 1.806 = Severe
As the race to find a vaccine or treatment for COVID-19 heats up, Mumbai-based Lupin became the second major Indian pharmaceutical company to be hit by a suspected ransomware attack in the last few weeks. The company was forced to shut down operations and production at several of its facilities for a brief period, but systems have been restored.
Individual Risk: No personal data was exposed in this incident.
Customers Impacted: 1,000
How it Could Affect Your Customers’ Business: Snarling systems and impacting production are two goals that we’re seeing on the rise on cybercriminal hit lists, and frequently ransomware is the tool that they prefer to shut down businesses.